Markets worried over the latest strain of COVID-19 - Tuesday Review, December 22

Markets worried over the latest strain of COVID-19 - Tuesday Review, December 22

President Trump was not happy with the latest stimulus. Markets were shaken by the idea of not receiving the much-needed aid

The US

Benchmarks closed lower as President Trump threatened not to sign the bill regarding the $900 billion stimulus package.

USA30 fell 0.67%, while USA500 lost 0.21%. TECH100 went up 0.51%.

Crude oil traded 1.02% lower at $47.48 a barrel.

Gold lost 0.80% to $1,867.75 per ounce.

Asia and Australia

The stocks closed in the red as the new strain of COVID-19 is threatening to trigger new lockdowns and restrictions.

Japan225 slipped 0.45%.

HongKong45 fell 0.33%.

Down under, Australia200 inched 0.95% lower.

Europe

Germany30 added 1.29%, while UK100 gained 0.6% even though the rapid spread of the mutant form of COVID-19 led to more stringent restrictions.

Brent oil lost 0.84% and traded at $50.48 per barrel.

EUR/USD was down 0.51% at 1.2179.

GBP/USD was 0.8% lower at 1.3358.

Sources: marketwatch.com, investing.com

The information presented herein is prepared by CAPEX.com and does not intend to constitute Investment Advice. The information herein is provided as a general marketing communication for information purposes only and as such it has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and it is not subject to any prohibition on dealing ahead of the dissemination of investment research.

Users/readers should not rely solely on the information presented herewith and should do their own research/analysis by also reading the actual underlying research. The content herewith is generic and does not take into consideration individual personal circumstances, investment experience or current financial situation.

Therefore, Key Way Investments Ltd shall not accept any responsibility for any losses of traders due to the use and the content of the information presented herein. Past performance is not a reliable indicator of future results.